Health Care/Hospital

Registration opens for Medtec China 2024

BEIJING, May 9, 2024 /PRNewswire/ -- According to the report of China Federation of Logistics & Purchasing (CFLP), the market size of China's medical device sector reachedRMB 1,250 billion in 2023, with a growth rate 2.4 times faster than that of the global medical device industry. To Vigorously ...

2024-05-09 00:00

Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts international conference on complex cardiac arrhythmias

AUSTIN, Texas, May 8, 2024 /PRNewswire/ -- On April 18-19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its seventh international symposium on complex arrhythmias, EPLive 2024. This year's event included 1,000 registered attendees from all over the glob...

2024-05-08 23:25 146

Front Street Re Appoints Edison Fong as Chief Executive Officer

GEORGETOWN, Cayman Islands, May 8, 2024 /PRNewswire/ -- Front Street Re  ("FSR" or the "Company"), an international Insurtech and reinsurance company that focuses on annuity, life, health, and general reinsurance solutions and is an operating subsidiary ofLexasure Fin...

2024-05-08 21:22 498

NeuShen Therapeutics Initiates First-in-Human Trial of NS-136, a Novel Selective M4 Receptor Positive Allosteric Modulator for the Treatment of Schizophrenia

SHANGHAI and LEXINGTON, Mass. , May 8, 2024 /PRNewswire/ -- NeuShen Therapeutics (the "Company"), a clinical-stage global biotechnology company dedicated to pioneering treatments for neurological and psychiatric disorders, today announced the dosing of the first healthy volunteer inAustralia in t...

2024-05-08 21:00 583

Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument

News Summary: * ACQUITY™ QDa™ II Mass Detector enhances confidence in routine compound identification using the specificity of mass analysis to boost efficiency, robustness, and productivity in LC-UV separations, while leveraging the Empower™ Chromatography Data System for complete traceabilit...

2024-05-08 20:40 554

Körber Pharma and Siemens Take the Lead in ABI Research's MES Software for Pharmaceutical, Biotechnology, and Cell & Gene Manufacturing Competitive Ranking

LONDON, May 8, 2024 /PRNewswire/ -- The new Competitive Assessment by global technology intelligence firmABI Research provides an in-depth and unbiased examination of the solutions offered by 13 manufacturing execution system (MES) software suppliers targeting pharmaceutical, biotech, and cell & ...

2024-05-08 20:30 562

TiumBio Announces Positive Topline Data from Phase 2a Trial of Merigolix in Patients with Moderate to Severe Endometriosis-Associated Pain

* The study (NCT05138562) met its primary endpoint of change of dysmenorrhea (menstrual pain) score from baseline to 12 weeks compared to placebo across all tested doses (120 mg, 240 mg, and 320 mg)  * Merigolix is expected to emerge as a best-in-class treatment based on its excellent pain re...

2024-05-08 20:00 525

Minghui Pharmaceutical to Present the Phase I/II Study of MHB088C (B7-H3 ADC) for the Treatment of Patients with Recurrent or Metastatic Solid Tumors in Late-breaking Oral Presentation at the 2024 ASCO Annual Meeting

SHANGHAI, May 8, 2024 /PRNewswire/ -- Minghui Pharmaceutical, Inc., a late-stage clinical biopharmaceutical company focused on autoimmune diseases and oncology, will feature Dr.Lin Shen from Beijing Cancer Hospital at the upcoming ASCO Annual Meeting inChicago. Dr. Shen will present the results f...

2024-05-08 18:18 3560

Andall Biosciences Introduces 23WELL: A Breakthrough New Brand with Ovary Care Capsules (1+1) as its Stellar Debut Product

SHANGHAI, May 8, 2024 /PRNewswire/ -- Andall Biosciences Inc. (ABI), a renowned biotechnology company at the forefront of life science research and applications, has made a significant stride with the introduction of their groundbreaking new product line, 23WELL. The brand takes center stage with...

2024-05-08 18:11 601

VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation

Empowering key ecosystem players to find each other easily and work together SINGAPORE, May 8, 2024 /PRNewswire/ -- VentureBlick announces the launch of Discovery, a groundbreaking networking platform designed to connect healthcare innovators, advisors, investors, distributors, partners, and serv...

2024-05-08 14:37 703

NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investments from Celadon Partners and ClavystBio

* Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearlyUS$400 million funding in total alongside significant business milestones * NSG BioLabs' partnerships with EnterpriseSG and ...

2024-05-08 10:00 990

Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Macau

SHANGHAI, May 8, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative medicines and vaccines, announced today that the Pharmaceutical Administration ...

2024-05-08 08:05 932

Newly Published Data in JAMA Cardiology Demonstrates Favorable Long-term Effects of the Corvia Atrial Shunt in Heart Failure Patients

Two years of echocardiographic data affirm positive effects of atrial shunt therapy on heart structure and function TEWKSBURY, Mass., May 8, 2024 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the publication in JAMA Cardi...

2024-05-08 06:17 847

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer

GAITHERSBURG, Md., May 8, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disease...

2024-05-08 04:20 1003

Santa J. Ono, University of Michigan President, Joins USJF Board

WASHINGTON, May 8, 2024 /PRNewswire/ -- Santa J. Ono, president of the University of Michigan, has joined the United States-Japan Foundation Board of Trustees. Ono, an accomplished medical researcher and leader in higher education across North America, is a second-generation Japanese American wh...

2024-05-08 04:00 861

Research Results on Jolly Good's Medical VR Will Be Presented for the First Time in the U.S. - Revealing Training VR for HALO Procedures at Large-Scale VR Seminar, SAEM2024

BROOKLINE, Mass., May 7, 2024 /PRNewswire/ -- Jolly Good US Inc. is proud to announce the groundbreaking debut of research findings on its Medical Virtual Reality (VR) platform inthe United States. This unveiling will take place at the annual meeting of the Society for Academic Emergency Medicine...

2024-05-08 02:00 920

"Momcozy Village" Campaign Elevates Support for Mothers with Upcoming Events and Initiatives

NEW YORK, May 7, 2024 /PRNewswire/ -- As we approach Mother's Day, Momcozy , a leader in maternal and infant care, is excited to share more details about its "Momcozy Village" campaign. This initiative focuses on stren...

2024-05-07 22:30 616

Seragon Completes Pre-Clinical Study of Aging Intervention Candidate SRN-901

IRVINE, Calif., May 7, 2024 /PRNewswire/ -- Seragon Biosciences, Inc. today announced the completion of a pre-clinical study on its novel anti-aging candidate, SRN-901. This pivotal study, conducted in mice, was undertaken to evaluate the impact of SRN-901 on aging as well as various health marke...

2024-05-07 22:10 934

FDA Grants Orphan Drug Designation to 9MW2821

SHANGHAI, May 7, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that its self-developed novel Nectin-4-targeting ADC (R&D code: 9MW2821) has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Adminis...

2024-05-07 22:00 676

Meihua International Medical Technologies Co., Ltd. to Present at the Emerging Growth Conference on May 9, 2024

Meihua International Medical Technologies Co., Ltd. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. YANGZHOU, China, May 7, 2024 /PRNewswire/ -- Meihua International Medical Tech...

2024-05-07 21:08 785
12345 ... 809